Accurate and timely diagnosisof infection status in infants born to women infected with human immunodeficiency virus (HIV) is of paramount importance. The comparative accuracy of five diagnostic decision rules was evaluated in 208 HIV-exposed infants (32 infected, 176 uninfected) based on laboratory testing during the first 6 months of life. Diagnostic rules A and B, which required single blood samples analyzed by culture and polymerase chain reaction (PCR) (rule A) or culture, PCR, and p24 antigen detection (rule B) were more prone to incorrect diagnoses than were rules requiring 2 blood samples analyzed by a singleassay (rule C) or combinations of culture and PCR (rules D and E). Rule D, which used PCR as the initial test, established the most useful algorithm: a positive PCR result followed by a positive culture in the second sample confirmed infected status, while two consecutive negativePCR results reconfirmed as negative at 6 months of age established uninfected status.
Although the requirement for positive results in virologic assays of at least 2 samples has recently been advocated [9, 10] , most studies of early diagnosis reported to date have not used repeat testing or combination of two or more assays to make a definitive diagnosis of HIV infection status. Also, the early diagnosis ofuninfected status in HIV-exposed infants has received scant attention. Early exclusion of HIV infection in exposed infants would minimize the need for prolonged antiretroviral use as well as Pneumocystis carinii pneumonia prophylaxis.
In a prospective study of HIV diagnosis in a cohort of HIVexposed infants, our objectives were to develop a diagnostic decision rule using common assays that could be applied prospectively to make a definitive diagnosis of infection status. We assessed the sensitivity, specificity, predictive values, and time to diagnosis for five sets of decision rules that required I or more blood samples and that used results of one or more assays consisting of viral culture of peripheral blood mononuclear cells (PBMC), qualitative DNA PCR in PBMC, and HIV p24 antigen detection in serum or plasma. On the basis of our results, we defined a practical algorithm for determining the infection status of an HIV-exposed infant. As far as we are aware, this is the first systematic analysis evaluating a set of diagnostic decision rules for determining HIV infection status among infants born to HIV-seropositive mothers.
Materials and Methods
Study population. The study population consisted of infants born to HIV-seropositive women at four hospitals in the New York metropolitanarea: North Shore University Hospital, Harlem Hospital, Metropolitan Hospital, and Kings County Hospital.
A minimum requirement for the study was to have at least 2 blood samples by age 6 months, with the first sample at age ,;;;3 months. Frequency of testing was planned for every 2-3 months through 2 years of age. For end points of the study, final infection status was determined on the basis of clinical outcome. A diagnosis of infected was based on the development of an AIDS-defining illness or seropositivity beyond 15 months of age. A diagnosis of uninfected was based on seroreversion at any age and absence of HIV-specific symptoms. By these criteria, 32 children were diagnosed as infected and 176 as uninfected. Eighty-four children were classified as being of indeterminate clinical status at the time of data analysis and were excluded from the analysis. All subjects who had reached an end point were ;;.12 months of age at the time of this report.
Sample preparation. About 5 mL of peripheral blood was drawn from infants during clinic visits and collected in tubes with and without an anticoagulant (heparin was replaced in 1992 with acid citrate dextran). Specimens were transported to the laboratory by courier service and usually processed within 6 h, with a maximum interval of 18 h. PBMC were separated by routine ficollhypaque techniques [11] and distributed for various assays. Plasma and sera were stored at -80°C.
Tests. Qualitative viral culture and PCR for HIV DNA were done in PBMC, and HIV p24 antigen determination was made in serum or plasma. In vitro HIV IgG antibody production was determined as well but was excluded from decision rules because a separate analysis [12] indicated this test to be of limited usefulness for early diagnosis.
Qualitative viral culture was done as described [13] using methods modified from procedures of Castro et al. [11] and Jackson and colleagues [14, 15] .
Qualitative DNA PCR was done as described [16] in cell pellets stored at -80°C in aliquots of 10 6 cells, which were lysed at the time of assay. After a hot-start DNA PCR in a thermocycler (Gene Amp PCR 9600; Perkin-Elmer Cetus, Norwalk, CT) consisting of 38 cycles (94°C, 1 min; 56°C, 1 min; trc. 1 min), the amplified product was electrophoresed in 1.5% agarose gel and transferred to a nylon membrane for Southern blot hybridization, using a 5' end-labeled SK19 oligonucleotide probe.
HIV p24 antigen detection was done in duplicate samples of serum or plasma, which were first subjected to acid hydrolysis [17] for dissociation of antigen-antibody complexes. HIV p24 antigen assays were done using ELISA kits (Coulter, Hialeah, FL) in accordance with the manufacturer's instructions.
HIV serology was done by ELISA at New York City Department of Health, Bureau of Laboratories, and positive reactions were confirmed by Western blot.
Diagnostic decision rules were developed with the aim of examining the comparative accuracy of diagnosis using one or more laboratory tests on 1 or more samples of blood (table 1) . These rules included single-sample combination-assay rules (A and B), a sequential-sample single-assay rule (C), and sequential-sample combination-assay rules (D and E). If a definite diagnosis could not be made by any rule at a specific time, the result was reported as indeterminate. Infants with indeterminate results were followed up until laboratory diagnosis was established according to each diagnostic decision rule.
Emerging evidence indicates that a substantial proportion of infants manifest a variable lag period after birth before becoming positive by viral culture or PCR, possibly because of transmission of HIV late in pregnancy or during delivery [18] . Retrospective analyses were therefore made to determine the optimal age at which a definitive diagnosis ofuninfected could be made by laboratory testing.
Statistical methods. Statistical analysis consisted of estimating the sensitivity and specificity of each of the decision rules, using the clinical reference standard definition of HIV infection as described above. With the exception of the individual assay results (table 2), which are determined collectively for all samples, the results of the diagnostic decision rules are expressed on a perpatient basis. A patient whose diagnostic result was considered indeterminate was included in all denominators.
We computed the positive and negative predictive values (PPV and NPV) of a diagnostic test with Bayes' rule [19] and using the observed HIV prevalence rate of 15% for this population. In anticipation of potential effects of future antiretroviral therapies aimed at preventing maternal-infant HIV transmission, we also calculated PPV and NPV on the basis of a prevalence rate of 10%.
We used the product-limit method [20] to analyze the time (age) until a definitive diagnosis was made. For each rule, if a patient's diagnosis was made at age T, and the previous blood sample had been drawn at age S (S < T), then the age at diagnosis was defined as the mean of Sand T to compensate for irregular and sometimes lengthy intersampling time intervals. If, on the other hand, the last blood sample had been drawn and assayed at age T with an indeterminate diagnosis, then the time until diagnosis was considered to be censored at age T (in accordance with statistical methods of survival analysis). A subset of infants from whom both samples were obtained before age 3 months was also subjected to independent analyses for time to diagnosis.
Results
Study cohort. The median age at the first sample was 0.7 month and that at the second sample was 2.2 months. In this cohort, 11 of 32 infected infants and 113 of 176 uninfected infants had the first analyses done by age :s;; 1 month.
Sensitivity and specificity of individual diagnostic assays. In planning the decision rules, results of each assay method were first analyzed to determine sensitivity and specificity of each technique at different ages (table 2). At age < 1 month, all three assay methods were done on samples from 9 infected infants, and 8 were positive by at least one assay. One of 2 infants first sampled at ,;;;48 h was positive by culture and PCR. Individual assays, positive for infected infants in this age group, were as follows: culture, 9 (75%) of 11; PCR, 9 (69%) of 11; and p24 antigen detection, 6 (67%) of9. False-positive results were observed in both PCR and culture, more frequently in the former; false-negatives occurred in all three assay systems, maximally in p24 antigen assays. Because of the occurrence of false-positive and false-negative results, no decision rules were developed to include analysis of a single sample with a single assay result. 
Results of diagnostic decision rules. Results of sensitivity
For sequential-sample rule C, when 2 or more samples were and specificity of various rules at ages~3 months and~6 obtained from infants~3 months of age, sensitivities were months are shown in figure 1.
83%, 79%, and 44%, respectively, for individual assays by
Sensitivities for single-sample rules A and B were 75% and culture, PCR, and p24 antigen, and specificities were 95%, 93%, respectively, at age~3 months and 79% and 90%, re-89%, and 88%, respectively. At age~6 months, sensitivities spectively, at age~6 months. Specificities for rules A and B using culture, PCR, and p24 antigen were 85%, 89%, and 58%, were 93% and 84%, respectively, at~3 months and 96% and respectively; specificities were 95%, 90%, and 90%, respec-90%, respectively, at~6 months.
tively. For both of the rules D and E, results were identical for 
Sensitivity B Specificity sensitivity (77%) and specificity (90%) at age "",3 months and for sensitivity (85%) and specificity (93%) at "",6 months. Incorrect and indeterminate diagnoses by various rules are summarized in table 3. Details of infected cases and of uninfected cases with false-negative and false-positive results, respectively, and their impact on diagnostic rules are shown in table 4 . In infected cases, the first sample obtained between 0.1 and 1.7 months was negative in 6 infants by both culture and PCR. One patient, 188, was misdiagnosed by all five rules. In total, rule A misdiagnosed all 6 infants, rule B misdiagnosed 3 infants, and rule C with p24 antigen detection misdiagnosed 2 infants. In uninfected infants, misdiagnoses were more common in rule B (single-sample rule) and rule C with PCR (sequential-sample rule), mainly because of the occurrence of false-positive PCR results. Examples of 2 cases with repeatedly false-positive results (including 1 with false-positive culture results) are shown in table 4. Among individual rules, the highest proportion of indetenninate diagnoses was observed with rule C with p24 antigen detection, occurring in 5 of 24 infected infants tested and 6 of 57 uninfected infants tested. rm 1996; 173 (January) Time until diagnosis. Estimated time until diagnosis (age at diagnosis) was derived from the product-limit method for children up to age 6 months (table 5). Infected status was diagnosed at an estimated median age of 0.8 months for assay methods that used a single sample (rules A and B). For assay methods that used at least 2 sequential samples, the estimated median ages to diagnosis ranged between 2 and 3 months for rules C with PCR, C with culture, D, and E and were slightly less (2.1, 2.1, 2.2, 2.2 months, respectively) for children who had 2 samples collected by age 3 months. For rule C with p24 antigen detection, the estimated median age of diagnosis of infected status was > 3 months in all instances. The estimated median age for diagnosis of a provisional uninfected status ranged from 1.0 to 4.0 months by various rules and was >99% correct (table 3) for rules C with culture, D, and E. Because of the lag time in diagnosis of infected status in some infants (table 4), it was decided that additional testing at age >6 months be done in all presumed uninfectedinfantsfor definitive diagnosis.
PPV and NPV. PPV and NPV were estimated on the basis of the observed transmission rate of 15% for this study. PPVs of ;;;.70% were obtained for rules A, C with culture, D, and E. NPVs of ;;;.90% were obtained for all assay rules (figure 2). At an estimated prevalence of 10% (in anticipation of a reduction in maternal HIV transmission through antiretroviral therapy during pregnancy), PPVs ranged from 39% for rule C with p24 antigen detection to 69% for rule A and NPVs ranged from 95% for rule C with p24 antigen detection to 99% for rules B and C with PCR ( figure 2 ).
An estimatewas made of the percentageof correct diagnoses in which indeterminate results were disregardedand only positive and negative results were compared with clinical outcome (table 3) . Percentage of correct diagnoses varied from 93% (rule B) to 100% (rules C with culture and C with p24 antigen detection) at ages ,;;;;3 months and from 91% (rule C with p24 antigen detection) to 99% (rules C with culture, D, and E) at ages ,;;;;6 months. Accuracy of diagnosis, which included indeterminate results,varied from 76% (rule C with p24 antigen detection)to 94% (rule C with culture) at ages ,;;;;3 months and from 80% (rule C with p24 antigen detection) to 93% (rules A and C with culture) at ages ,;;;;6 months (table 3) .
Discussion
Definitive diagnosisof infectionstatus of infants with perinatal exposureis of paramountimportanceboth for making therapeutic decisionsand for evaluatingefficacyoftherapeutic interventions aimed at preventing HIV transmission. In this study, we have taken the most commonly used laboratory diagnostic tests for HIV infectionto developa series of diagnosticdecision rules, which were applied prospectively to a cohort of HIVexposedinfants.Theserules incorporatedcommonlyused diagnostic tests, either individually or in combination, on blood samples obtained in the first 6 months of life for making a laboratory diagnosis of uninfected status should be confirmed samples are more likely to provide accurate results than those by sampling done at age~6 months. based on a single sample; PCR is a good screening test, but Criteria currently recommended by the Centers for Disease an alternative test such as viral culture should be used for Control and Prevention for laboratory diagnosis of HIV infecconfirmingdiagnosis of infected status. Time to correct laboration require that at least 2 samples be obtained from the infant, tory diagnosis of infected status depends largely on frequency but a single assay such as PCR is considered adequate [10] . of sampling, and in most infants it can be made by 3 months, The importance of using at least 2 blood samples is underscored but the lag time to culture or PCR positivity may sometimes by results of the present study, in which incorrect diagnoses occurred maximally with the single-sample rules for both infected and uninfected infants, even though results of at least two assay methods were required. Moreover, errors including sample mix-ups and technical inconsistencies can irreversibly affect diagnosis based on single samples [10] . We disagree, however, with the use of a single assay such as PCR, which has been considered sufficient to make a diagnosis of infected if positive on at least 2 separate blood samples. Our results indicate that use of PCR by itself can prove erroneous, as we saw positive PCR results in ;;;.2 samples from 7 of 163 uninfected infants and have recently reported results for 3 of these infants [21] . Although it is unlikely, we cannot definitely rule out the possibility of technical reasons for false-positive PCR results. We took extreme precautions during the assay and confirmed results with primer pairs directed to other genes besides gag-env V3, LTR, and pol-using stored samples.
The biologic relevance of transiently positive PCR results is at present unknown. One of the 7 infants with transiently positive PCR results was also positive by viral culture. One possible explanation is that these infants were inoculated with the virus during pregnancy or delivery but the virus failed to establish a productive infection or was effectively cleared. Such a possibility has been recently reported in a child with transiently positive viral culture [22] . Alternatively, some infants may have acquired defective or nonreplicative viruses, which would result in positive DNA PCR result but negative viral cultures. Regardless of the cause for these findings, the results suggest that although PCR is a highly useful screening test, the risk of making an erroneous diagnosis of infected is high enough to merit the need of a test other than PCR, such as viral culture, in the second sample for confirming a diagnosis of infected.
On the basis of our data, we conclude that rules with the maximum efficiency and accuracy are those using sequential samples, which in this study consisted ofrule C for viral culture and the combination-assay rules D and E incorporating PCR and culture. At the observed transmission rate of 15%, PPVs of >70% and NPVs of >90% were obtained for these rules. Indeterminate results were obtained with all rules for both known infected and uninfected children (except rule B), persisting in a few children up to and beyond 6 months of age. As described above, transiently positive PCR results also contributed to indeterminate diagnoses in certain rules incorporating PCR. Failure to make a timely or definitive (or both) diagnosis was due largely to failure to obtain follow-up samples or prolonged intervals between visits in some infants, a pattern not atypical in inner city settings.
Age at first positive result by culture or PCR is considered by some investigators to be a useful guide to presumed timing of transmission of HIV from the mother, whether occurring in utero or intrapartum. The difficulty of obtaining samples within 48 h of birth precluded any analysis of presumed timing of transmission in this cohort. However, an important observation in this study was the extended delay that might occur before laboratory tests such as PCR and culture become positive in infected infants. In our cohort, the lag period in 1 infant for positivity by HIV culture, PCR, and p24 antigen detection persisted beyond 4.0 months (table  4 ). An implication of this observation is that the currently proposed definition of timing of transmission [18] may potentially lead to misdiagnoses of infected infants because it only considers the time interval from birth to 3 months. Although not stated as such in the definition, a negative result beyond 3 months of life may be misconstrued to imply an absence of vertical transmission. It may be advisable to modify the definition for intrapartum transmission to delete the 3-month limit and to include all cases who are initially negative for HIV and become positive at ;;;.1 week of age in the absence of other risk factors, such as breast feeding. Moreover, it is important to retest all presumed uninfected infants at age ;;;.6 months to ensure that there is no infected infant with delayed positive test results.
For economy, practicality, and accuracy of diagnosis of HIV infection status in infants born to HIV-seropositive women, we recommend an algorithm such as rule D, using PCR as the initial test. IfPCR is positive, then either culture or an alternative test other than PCR should be used for making a diagnosis of infected status. As we develop effective antiretroviral therapies, however, it would be remiss not to initiate therapy on the basis of a single positive PCR result, provided that a sample is processed for confirmation ------------------------, 100 r---------==,..-------==----------....., .PPV~NPV by culture at the time of starting treatment. It is our opinion that the reliability of two PCR results on sequential samples is valid only for a diagnosis of uninfected status. As such, a repeat PCR is warranted only if the first PCR is negative and should be reconfirmed at age~6 months. The recommended algorithm of rule D is especially practical for large centers that are involved in delivery of clinical care to Hlvexposed infants and are in need of making diagnostic decisions but depend on outside laboratories for testing blood samples. Newer methodologies, such as HIV RNA determination in plasma, hold promise for enhancing our ability to diagnose infection status in HIV-exposed infants.
